Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy

Medical Microbiology and Immunology

Volumn 199, Issue 2, 2010, Pages 139-143

  Palecek, Tomas ^a,e   Kuchynka, Petr ^a   Hulinska, Dagmar ^b   Schramlova, Jana ^b   Hrbackova, Hana ^b   Vitkova, Ivana ^a   Simek, Stanislav ^a   Horak, Jan ^a   Louch, William E ^c,d   Linhart, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Borrelia burgdorferi; Ceftriax; Dilated cardiomyopathy; Endomyocardial biopsy

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ARTICLE; BACTERIUM DETECTION; BORRELIA BURGDORFERI; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CZECH REPUBLIC; DRUG EFFICACY; ELECTRON MICROSCOPY; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; LYME DISEASE; MALE; NONHUMAN; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BIOPSY; BORRELIA BURGDORFERI; CARDIOMYOPATHY, DILATED; CEFTRIAXONE; CZECH REPUBLIC; FEMALE; HUMANS; LYME DISEASE; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MYOCARDIUM; POLYMERASE CHAIN REACTION; PREVALENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953290064     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0141-6     Document Type: Article

References (21)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuwelt S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270-276
2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of cardiomyopathies. Circulation 113:1807-1816
3. Kühl U, Pauschinger M, Noutsias M, Kapp JF, Schultheiss HP (2002) Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J 4(Suppl I):I73-I80
4. Steere AC (2001) Lyme disease. N Engl J Med 345:115-125
5. Cox J, Krajden M (1991) Cardiovascular manifestation of lyme disease. Am Heart J 122:1449-1455
6. Bartunek P, Gorican K, Veiser T, Taborsky M, Hulinska D (2007) Significance of Borrelia infection in development of dilated cardiomyopathy (a pilot study). Prague Med Rep 108:339-347
7. Franz JK, Krause A (2003) Lyme disease (Lyme borreiolosis). Best Pract Res Clin Rheumatol 17:241-264
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography0s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463
9. Weyman AE, Doty WD (1982) Left ventricle. In: Weyman AE (ed) Cross sectional echocardiography. Lea and Febiger, Philadelphia, p 267
10. Aretz HT (1987) Myocarditis: the dallas criteria. Hum Pathol 18:619-624
11. Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic inflammatory process in dilated cardiomyopathy. Heart 75:295-300 (Pubitemid 26094969)
12. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with " idiopathic" left ventricular dysfunction. Circulation 111:887-893
13. Lelovas P, Donbas I, Bassiakou E, Xanthos T (2008) Cardiac implications of lyme disease, diagnosis and therapeutic approach. Int J Cardiol 129:15-21
14. Pankuweit S, Hufnagel G, Eckhardt H, Hermann H, Uttecht S, Maisch B (1998) Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin (Munich) 93:223-228
15. Rostoff P, Gajos G, Konduracka E, Gackowski A, Neseper J, Piwowarska W (2009) Lyme carditis: epidemiology, pathophysiology, and clinical features in endemic areas. Int J Cardiol. doi: 10.1016/j.ijcard.2009.03.034
16. Stanek G, Klein J, Bittner R, Glogar D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322:249-252
17. Suedkamp M, Lissel C, Eiffert H, Flesch M, Boehm M, Mehlhorn U, Thomssen R, de Vivie ER (1999) Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J 138:1198-1199
18. Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Pongratz S, Klein W, Furian C, Pierer K (1992) Reversal by ceftriaxone of dilated cardiomyopathy borrelia burgdorferi infection. Lancet 339:1174-1175
19. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39-45
20. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857-863
21. Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J (2005) Myocardial biopsy based classification and treatment in patiens with dilated cardiomyopathy. Int J Cardiol 104:92-100